Welcome to the Medicines Safety Dashboard
The medicines safety dashboard is a tool being developed to support the identification of best practice, opportunities for improvement and supporting spread and adoption across the nation.
It utilises a set of prescribing indicators that have been developed as part of a programme of work to promote safer use of medicines, including prescribing, dispensing, administration and monitoring.
The purpose of the indicators are to support reductions in hospital admissions that may be associated with prescribing, to reduce the risk of avoidable medicines related harms and to quantify patients at potentially increased medicines related safety risk.
- The content is based on consideration of the medicines safety related indicators that are available in the growing number of ‘dashboards’, related information sources and data sets available.
- The MSD only contains a selected number of medicines safety indicators but more can be added to align with national priorities as the national medicines safety programme develops.
- This MSD approach is aimed at developing and supporting collaborative based working across the nation on improving medication safety on MSD indicators areas of interest.
- The initial content is based on consideration of the indicators available within the ePACT2 data warehouse and the Open-prescribing website. There will be the option to include indicators from other information sources as this approach is developed.
- The MSD does not state where best practice targets are for the indicators involved, in recognition of the fact that specific best practice positions may be dependent on local circumstances and therefore should be locally determined.
Ref Opioids Prescribing Indicators
O1 Continuous prescribing of opiates for more than 12 month
O2 High dose opioids as percentage regular opioids by all CCGs
O3 High dose opioids per 1000 patients by all CCGs
O4 Opioids - total oral morphine equivalence by CCG
O5 Anxiolytics and Hypnotics - Average Daily Quantity per item by all CCGs
O6 Prescribing of gabapentin and pregabalin (DDD) by all CCGs
O7 Prescribing of pregabalin by all CCGs
Ref Polypharmacy Indicators
IP7 Average number of unique medicines per patient
IP8 Percentage of patients prescribed 8≥ unique medicines
IP10 Percentage of patients prescribed 10≥ unique medicines
IP15 Percentage of patients prescribed 15 ≥ unique medicines
IP20 Percentage of patients prescribed 20 ≥ unique medicines
Ref Anticoagulant Indicators
IP6 Percentage of patients prescribed multiple anticoagulant regimes
S2 (GIB02) Patients ≥18 years old prescribed a NSAID and concurrently prescribed an oral anticoagulant (warfarin or NOAC)
S3 (GIB0) Patients ≥18 years old prescribed an oral anticoagulant (warfarin or a non-vitamin K antagonist oral anticoagulant (NOAC)) with an anti-platelet and NOT concurrently prescribed a gastroprotective medicine
Ref Additional Polypharmacy Indicators
P1.85 The average number of unique medicines prescribed per patient - for patients ≥85 years old
P2.75 Percentage of patients with an anticholinergic burden score of 6 or more aged 75 and over
P3.9 Percentage of patients with an anticholinergic burden score ≥9
P4 Percentage of patients prescribed medicines likely to cause Acute Kidney Injury DAMN (Diuretics/ACI&ARBs/Metformin/NSAIDS) drugs
P5 Percentage of patients prescribed a NSAID and ≥ 1 other unique medicines likely to cause kidney injury (DAMN drugs)
Ref Gastrointestinal Bleed Risk Indicators
S1 (GIB01) Patients ≥65 years old prescribed a NSAID and NOT concurrently prescribed a gastro-protective medicine
S4 (GIB04) Patients ≥18 years old prescribed aspirin and another antiplatelet and NOT concurrently prescribed a gastro-protective medicine
S5 (GIBC1) Composite Gastro Intestinal Bleeds comprising of unique patients from indicators 1 to 4
S6 v Total volumes of oral NSAIDS (ADQs per STARPU)